Ribavirin administration alters ectonucleotidase activities in experimental autoimmune encephalomyelitis.

The role of extracellular purines and purinoreceptors in the pathophysiology of different neurological disorders is the focus of rapidly expanding area of research. Ectonucleotidases are the enzymes with multiple roles in extracellular nucleotides metabolism and regulation of nucleotidebased intercellular signaling. The aim of present study was to investigate the changes in the ATP, ADP and AMP hydrolyzing activities after ribavirin treatment in spinal cord during experimental autoimmune encephalomyelitis (EAE). Our results demonstrate that ribavirin itself had no significant effect on ectoenzyme activities, when tested in vitro and in vivo on spinal cord crude membrane preparation of intact animals. We observed significant increase in ATP, ADP and AMP hydrolyzing activity in the spinal cord crude membrane preparation in EAE animals at 15 days post immunization compared to control animals. The increase was registered at 28 days post immunization, as well. At same time points, ribavirin treatment decreased ATP, ADP and AMP hydrolyzing activity compared to EAE animals. In addition, no significant changes 8 days post immunization was observed between EAE-induced and ribavirin- treated EAE animals and these levels were similar to control level. Thus, we suppose that ribavirin-induced alteration in ectonucleotidase activities is rather due to its suppression of inflammation, than to its direct action on ATP, ADP and AMP hydrolysis.

[1]  S. Jalkanen,et al.  IFN‐β regulates CD73 and adenosine expression at the blood–brain barrier , 2008, European journal of immunology.

[2]  L. Rakić,et al.  Ribavirin ameliorates experimental autoimmune encephalomyelitis in rats and modulates cytokine production. , 2008, International immunopharmacology.

[3]  S. Jalkanen,et al.  CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis , 2008, Proceedings of the National Academy of Sciences.

[4]  T. Krahn,et al.  CD73-Generated Adenosine Restricts Lymphocyte Migration into Draining Lymph Nodes1 , 2008, The Journal of Immunology.

[5]  G. Yegutkin.  Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. , 2008, Biochimica et biophysica acta.

[6]  Saša Virijević Jovanović,et al.  Therapeutic effects of combined treatment with ribavirin and tiazofurin on experimental autoimmune encephalomyelitis development: Clinical and histopathological evaluation , 2008, Journal of the Neurological Sciences.

[7]  S. Jalkanen,et al.  VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[8]  P. Rossini,et al.  Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. , 2007, Blood.

[9]  V. Kuchroo,et al.  Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression , 2007, The Journal of experimental medicine.

[10]  R. Lisak.  Neurodegeneration in multiple sclerosis , 2007, Neurology.

[11]  D. Friedman,et al.  CD39 and control of cellular immune responses , 2007, Purinergic Signalling.

[12]  Jonathan A. Rebhahn,et al.  T Regulatory and Primed Uncommitted CD4 T Cells Express CD73, Which Suppresses Effector CD4 T Cells by Converting 5′-Adenosine Monophosphate to Adenosine1 , 2006, The Journal of Immunology.

[13]  Hans Lassmann,et al.  Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. , 2006, Brain : a journal of neurology.

[14]  S. Colgan,et al.  Physiological roles for ecto-5’-nucleotidase (CD73) , 2006, Purinergic Signalling.

[15]  J. Sévigny,et al.  The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance , 2006, Purinergic Signalling.

[16]  V. Morsch,et al.  Apyrase and 5′-nucleotidase Activities in Synaptosomes from the Cerebral Cortex of Rats Experimentally Demyelinated with Ethidium Bromide and Treated with Interferon-β , 2006, Neurochemical Research.

[17]  B. Engelhardt.  Molecular mechanisms involved in T cell migration across the blood–brain barrier , 2006, Journal of Neural Transmission.

[18]  V. Morsch,et al.  HIV infection is associated with increased NTPDase activity that correlates with CD39-positive lymphocytes. , 2005, Biochimica et biophysica acta.

[19]  Li V. Yang,et al.  CD73 and Ly-6A/E Distinguish In Vivo Primed but Uncommitted Mouse CD4 T Cells from Type 1 or Type 2 Effector Cells1 , 2005, The Journal of Immunology.

[20]  E. Vizi,et al.  Adenosine receptor signaling in the brain immune system. , 2005, Trends in pharmacological sciences.

[21]  L. Rakić,et al.  Downregulation of Glial Scarring after Brain Injury: The Effect of Purine Nucleoside Analogue Ribavirin , 2005, Annals of the New York Academy of Sciences.

[22]  W. Parker,et al.  Metabolism and antiviral activity of ribavirin. , 2005, Virus research.

[23]  S. Colgan,et al.  Crucial Role for Ecto-5′-Nucleotidase (CD73) in Vascular Leakage during Hypoxia , 2004, The Journal of experimental medicine.

[24]  M. Mostarica‐Stojković,et al.  Induction of experimental autoimmune encephalomyelitis in Dark Agouti rats without adjuvant , 2004, Clinical and experimental immunology.

[25]  E. Oláh,et al.  Targeting signal transduction. , 2003, Advances in enzyme regulation.

[26]  L. Rakić,et al.  Ribavirin reduces clinical signs and pathological changes of experimental autoimmune encephalomyelitis in Dark Agouti rats , 2003, Journal of neuroscience research.

[27]  A. Gewirtz,et al.  Secretion of IL-2 and IFN-γ, But Not IL-4, by Antigen-Specific T Cells Requires Extracellular ATP1 , 2003, The Journal of Immunology.

[28]  B. Trapp,et al.  Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease , 2003, Journal of the Neurological Sciences.

[29]  M. Mostarica‐Stojković,et al.  Down-regulation of experimental allergic encephalomyelitis in DA rats by tiazofurin , 2002, Journal of Neuroimmunology.

[30]  M. J. Broekman,et al.  Role of extracellular ATP metabolism in regulation of platelet reactivity. , 2002, The Journal of laboratory and clinical medicine.

[31]  N. Rothwell,et al.  Extracellular ATP and P2X7 receptors in neurodegeneration. , 2002, European journal of pharmacology.

[32]  S. Hodgkinson,et al.  Mycophenolate mofetil treatment accelerates recovery from experimental allergic encephalomyelitis. , 2001, International immunopharmacology.

[33]  S. Colgan,et al.  Regulation of Endothelial CD73 by Adenosine: Paracrine Pathway for Enhanced Endothelial Barrier Function1 , 2000, The Journal of Immunology.

[34]  Kazuhide Inoue,et al.  Extracellular ATP Triggers Tumor Necrosis Factor‐α Release from Rat Microglia , 2000 .

[35]  G. Guidotti,et al.  Widespread expression of ecto-apyrase (CD39) in the central nervous system , 1998, Brain Research.

[36]  M. Stojiljkovic,et al.  Properties of Mg(2+)-ATPase rat brain synaptic plasma membranes. , 1998, General physiology and biophysics.

[37]  F. Di Virgilio,et al.  Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. , 1997, Journal of immunology.

[38]  R. Mrsny,et al.  Surface expression, polarization, and functional significance of CD73 in human intestinal epithelia. , 1997, The Journal of clinical investigation.

[39]  J. Merrill,et al.  Cytokines in inflammatory brain lesions: helpful and harmful , 1996, Trends in Neurosciences.

[40]  Ting-Fang Wang,et al.  CD39 Is an Ecto-(Ca,Mg)-apyrase (*) , 1996, The Journal of Biological Chemistry.

[41]  H. Zimmermann,et al.  Immunocytochemical localization of ecto-5′-nucleotidase in cultures of cerebellar granule cells , 1996, Neuroscience.

[42]  G. Sutherland,et al.  The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization. , 1994, Journal of immunology.

[43]  S. Duensing,et al.  CD39 as a novel marker of in vivo immune activation. , 1994, Blood.

[44]  C. Crumpacker,et al.  Inhibition of immune functions by antiviral drugs. , 1991, The Journal of clinical investigation.

[45]  G. Wood,et al.  Expression, distribution, and biochemistry of human CD39. Role in activation-associated homotypic adhesion of lymphocytes. , 1991, Journal of immunology.

[46]  R. Ardaillou,et al.  Induction of ecto-5'-nucleotidase of rat cultured mesangial cells by interleukin-1 beta and tumour necrosis factor-alpha. , 1990, Immunology.

[47]  W. B. Jolley,et al.  Long-term skin allograft survival by combined therapy with suboptimal dose of cyclosporine and ribavirin. , 1988, Transplantation proceedings.

[48]  L. Thompson,et al.  Distribution of ecto-5'-nucleotidase on subsets of human T and B lymphocytes as detected by indirect immunofluorescence using goat antibodies. , 1987, Journal of immunology.

[49]  W. Koff,et al.  Inhibition of lymphocyte proliferative responses by ribavirin , 1980, Infection and immunity.

[50]  N. Tolbert,et al.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. , 1978, Analytical biochemistry.

[51]  R. K. Robins,et al.  Broad-Spectrum Antiviral Activity of Virazole: 1-f8- D-Ribofuranosyl- 1,2,4-triazole- 3-carboxamide , 1972, Science.

[52]  M. Bours,et al.  Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. , 2006, Pharmacology & therapeutics.

[53]  M. Stojiljkovic,et al.  Ecto-ATPase and ecto-ATP-diphosphohydrolase are co-localized in rat hippocampal and caudate nucleus synaptic plasma membranes. , 2003, Physiological research.

[54]  A. Compston,et al.  Multiple sclerosis. , 2002, Lancet.

[55]  H. Zimmermann.  Ectonucleotidases: Some recent developments and a note on nomenclature , 2001 .

[56]  R. Penniall.  An improved method for the determination of inorganic phosphate by the isobutanol-benzene extraction procedure☆ , 1966 .